vs
KADANT INC（KAI）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
KADANT INC的季度营收约是Ultragenyx Pharmaceutical Inc.的1.3倍（$271.6M vs $207.3M），KADANT INC净利率更高（10.2% vs -62.0%，领先72.2%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -0.0%），KADANT INC自由现金流更多（$44.1M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 6.7%）
Kadant Inc.创立于1991年，最初是Thermo Electron的子公司，部分股权私有、部分公开交易，2001年完成完全分拆并启用现名。公司服务于造纸、废纸回收、木材加工、物料搬运等多个加工领域，是业务覆盖亚洲、欧洲、北美、南美的跨国企业。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
KAI vs RARE — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $271.6M | $207.3M |
| 净利润 | $27.7M | $-128.6M |
| 毛利率 | 45.2% | — |
| 营业利润率 | 15.7% | -54.7% |
| 净利率 | 10.2% | -62.0% |
| 营收同比 | -0.0% | 25.9% |
| 净利润同比 | -12.2% | 3.5% |
| 每股收益（稀释后） | $2.35 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $207.3M | ||
| Q3 25 | $271.6M | $159.9M | ||
| Q2 25 | $255.3M | $166.5M | ||
| Q1 25 | $239.2M | $139.3M | ||
| Q4 24 | $258.0M | $164.6M | ||
| Q3 24 | $271.6M | $139.5M | ||
| Q2 24 | $274.8M | $147.0M | ||
| Q1 24 | $249.0M | $108.8M |
| Q4 25 | — | $-128.6M | ||
| Q3 25 | $27.7M | $-180.4M | ||
| Q2 25 | $26.2M | $-115.0M | ||
| Q1 25 | $24.1M | $-151.1M | ||
| Q4 24 | $24.0M | $-133.2M | ||
| Q3 24 | $31.6M | $-133.5M | ||
| Q2 24 | $31.3M | $-131.6M | ||
| Q1 24 | $24.7M | $-170.7M |
| Q4 25 | — | — | ||
| Q3 25 | 45.2% | — | ||
| Q2 25 | 45.9% | — | ||
| Q1 25 | 46.1% | — | ||
| Q4 24 | 43.4% | — | ||
| Q3 24 | 44.7% | — | ||
| Q2 24 | 44.4% | — | ||
| Q1 24 | 44.6% | — |
| Q4 25 | — | -54.7% | ||
| Q3 25 | 15.7% | -106.9% | ||
| Q2 25 | 15.4% | -64.8% | ||
| Q1 25 | 14.9% | -102.6% | ||
| Q4 24 | 14.3% | -74.3% | ||
| Q3 24 | 18.0% | -94.6% | ||
| Q2 24 | 17.6% | -79.1% | ||
| Q1 24 | 14.8% | -151.9% |
| Q4 25 | — | -62.0% | ||
| Q3 25 | 10.2% | -112.8% | ||
| Q2 25 | 10.2% | -69.0% | ||
| Q1 25 | 10.1% | -108.5% | ||
| Q4 24 | 9.3% | -80.9% | ||
| Q3 24 | 11.6% | -95.7% | ||
| Q2 24 | 11.4% | -89.5% | ||
| Q1 24 | 9.9% | -156.8% |
| Q4 25 | — | $-1.28 | ||
| Q3 25 | $2.35 | $-1.81 | ||
| Q2 25 | $2.22 | $-1.17 | ||
| Q1 25 | $2.04 | $-1.57 | ||
| Q4 24 | $2.04 | $-1.34 | ||
| Q3 24 | $2.68 | $-1.40 | ||
| Q2 24 | $2.66 | $-1.52 | ||
| Q1 24 | $2.10 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $124.5M | $421.0M |
| 总债务越低越好 | $254.6M | — |
| 股东权益账面价值 | $949.8M | $-80.0M |
| 总资产 | $1.5B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.27× | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $421.0M | ||
| Q3 25 | $124.5M | $202.5M | ||
| Q2 25 | $95.3M | $176.3M | ||
| Q1 25 | $91.7M | $127.1M | ||
| Q4 24 | $94.7M | $174.0M | ||
| Q3 24 | $88.4M | $150.6M | ||
| Q2 24 | $73.8M | $480.7M | ||
| Q1 24 | $81.4M | $112.3M |
| Q4 25 | — | — | ||
| Q3 25 | $254.6M | — | ||
| Q2 25 | $245.7M | — | ||
| Q1 25 | $273.5M | — | ||
| Q4 24 | $285.2M | — | ||
| Q3 24 | $323.2M | — | ||
| Q2 24 | $342.0M | — | ||
| Q1 24 | $306.8M | — |
| Q4 25 | — | $-80.0M | ||
| Q3 25 | $949.8M | $9.2M | ||
| Q2 25 | $926.0M | $151.3M | ||
| Q1 25 | $876.0M | $144.2M | ||
| Q4 24 | $847.1M | $255.0M | ||
| Q3 24 | $851.7M | $346.8M | ||
| Q2 24 | $807.7M | $432.4M | ||
| Q1 24 | $782.7M | $140.3M |
| Q4 25 | — | $1.5B | ||
| Q3 25 | $1.5B | $1.2B | ||
| Q2 25 | $1.5B | $1.3B | ||
| Q1 25 | $1.4B | $1.3B | ||
| Q4 24 | $1.4B | $1.5B | ||
| Q3 24 | $1.5B | $1.5B | ||
| Q2 24 | $1.5B | $1.6B | ||
| Q1 24 | $1.4B | $1.3B |
| Q4 25 | — | — | ||
| Q3 25 | 0.27× | — | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | 0.31× | — | ||
| Q4 24 | 0.34× | — | ||
| Q3 24 | 0.38× | — | ||
| Q2 24 | 0.42× | — | ||
| Q1 24 | 0.39× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $47.3M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $44.1M | $-100.8M |
| 自由现金流率自由现金流/营收 | 16.2% | -48.6% |
| 资本支出强度资本支出/营收 | 1.2% | 0.5% |
| 现金转化率经营现金流/净利润 | 1.70× | — |
| 过去12个月自由现金流最近4个季度 | $145.9M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | — | $-99.8M | ||
| Q3 25 | $47.3M | $-91.4M | ||
| Q2 25 | $40.5M | $-108.3M | ||
| Q1 25 | $22.8M | $-166.5M | ||
| Q4 24 | $51.9M | $-79.3M | ||
| Q3 24 | $52.5M | $-67.0M | ||
| Q2 24 | $28.1M | $-77.0M | ||
| Q1 24 | $22.8M | $-190.7M |
| Q4 25 | — | $-100.8M | ||
| Q3 25 | $44.1M | $-92.7M | ||
| Q2 25 | $36.5M | $-110.7M | ||
| Q1 25 | $19.0M | $-167.8M | ||
| Q4 24 | $46.3M | $-79.5M | ||
| Q3 24 | $48.3M | $-68.6M | ||
| Q2 24 | $23.1M | $-79.0M | ||
| Q1 24 | $16.6M | $-193.9M |
| Q4 25 | — | -48.6% | ||
| Q3 25 | 16.2% | -58.0% | ||
| Q2 25 | 14.3% | -66.5% | ||
| Q1 25 | 7.9% | -120.5% | ||
| Q4 24 | 17.9% | -48.3% | ||
| Q3 24 | 17.8% | -49.2% | ||
| Q2 24 | 8.4% | -53.7% | ||
| Q1 24 | 6.7% | -178.2% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | 1.2% | 0.8% | ||
| Q2 25 | 1.6% | 1.5% | ||
| Q1 25 | 1.6% | 1.0% | ||
| Q4 24 | 2.2% | 0.1% | ||
| Q3 24 | 1.5% | 1.2% | ||
| Q2 24 | 1.8% | 1.4% | ||
| Q1 24 | 2.5% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.55× | — | ||
| Q1 25 | 0.95× | — | ||
| Q4 24 | 2.16× | — | ||
| Q3 24 | 1.66× | — | ||
| Q2 24 | 0.90× | — | ||
| Q1 24 | 0.92× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KAI
| Flow Control | $94.8M | 35% |
| Capital | $83.2M | 31% |
| Material Handling Systems | $70.3M | 26% |
| Transferred Over Time | $17.1M | 6% |
| Other | $6.1M | 2% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
